“There was a very provocative idea in the field that these cells come into the blood early on…The tumor was removed early, so why are these cells re-emerging after 20 years? The cells have to come from the DCIS. But how do we connect the dots? If you look at blood from DCIS patients, do you find tumor cells in the blood?” – Dr. Sunitha Nagrath

“For a long time, I resisted using machine learning. I didn’t like it; I didn’t trust it,.. AI models have thousands of parameters without clear meaning, [so] it appeared to me as lazy-man science. It wasn’t until I was frustrated to the bottom of my stomach with our inability to predict these interactions that I said ‘yea, let’s try it.’” – Nicholas Kotov

The Distinguished Leadership Award is conferred upon undergraduate and graduate students of the College of Engineering who have demonstrated outstanding leadership and service to the College, University, and community.

Congratulations to Fjorela on achieving this accomplishment!

BI would like to congratulate EI Therapeutics on making the 2025 Renaissance Ventures HotList! The HotList represents high-promise, early-stage companies expected to raise venture capital within the next 12-18 months.

Election to the National Academy of Engineering is among the highest professional distinctions accorded to an engineer. Academy membership honors those who have made outstanding contributions in at least one of the following categories: “engineering practice, research, or education”, “pioneering of new and developing fields of technology, major advancements in traditional fields of engineering, or development/implementation of innovative approaches to engineering education” or “engineering leadership of one or more major endeavors.”

“Traditional pathogen-based vaccines have numerous drawbacks that limit their benefits for treating cancer and chronic or preexisting infections. As COVID-19 demonstrated, mRNA vaccines avoid some of these drawbacks and can be very effective, but there is still much room for improvement,” – Dr. Guizhi (Julian) Zhu

“My professional path at Michigan has been a direct consequence of student, post-doc, and faculty collaborators who have made my work in the department, college, and university so fulfilling.” – Dr. Michael Solomon

As a part of a research group led by Dr. Aaron Morris, Dr. Lonnie Shea assists in identifying new therapeutics in models of primary progressive multiple sclerosis (PPMS). They hope to achieve this by delving deeper into the disease’s cellular mechanisms.